{
  "trial_id": "NCT01957332",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "first presentation of MBC, regardless of ER and HER2 status of the primary tumor",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "eligible for first-line systemic therapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "non-rapidly progressive MBC, not requiring urgent initiation of chemotherapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "no recent significant worsening of MBC related signs and symptoms according to patient history",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "liver metastases: no significant increase in liver function tests alanine aminotransferase aspartate transaminase (ASAT) and alanine transaminase (ALAT) in 2 weeks prior to screening visit",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "standard imaging work-up of MBC was recently performed",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "measurable or clinically evaluable disease on recent standard work up of MBC",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "histological biopsy can safely be obtained according to standard clinical care procedures",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "primary tumor blocks available for confirmatory central laboratory ER/HER2 testing in the UMCG",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "WHO performance status 0-2",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "patient is able to undergo PET imaging procedures",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "age >18 years of age, willing and able to comply with the protocol as judged by the investigator",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "contraindications for systemic treatment (as will be assigned based on biopsy and experimental scan results)",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "pregnant or lactating women",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "prior allergic reaction to immunoglobulins or immunoglobulin allergy",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "inability to comply with study procedures",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "rapidly progressive (visceral) disease requiring rapid initiation of chemotherapy",
      "label": "triggers",
      "evidence": "unknown"
    }
  ],
  "notes": "The patient is a 42 year-old postmenopausal woman who had a screening sonogram which revealed an abnormality in the right breast. She had no palpable masses on breast exam.",
  "_meta": {
    "topic_id": "25",
    "trial_id": "NCT01957332",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}